Pharma IQ Members

Kate
Hammeke

When looking at overall spending for 2011 and projected outsourcing spend for 2012, one can determine which customer segments to target based on how the services offered by providers compare to the needs of each segment. Big Pharma showed an increased need for bio-analytical testing, process optimization, stability storage and testing, cytotoxic...Full Article »